(EMAILWIRE.COM, August 17, 2018 ) The report "Cell Counting Market by Product (Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer), Consumables (Reagent, Assay Kits, Microplate)), End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2023", The cell counting market is expected to reach USD 12.32 billion by 2023 from an estimated USD 8.84 billion in 2018, at a CAGR of 6.8%. The major factors driving the growth of this market include the growing incidence of diseases and disorders, development of enhanced solutions and improved image analysis, and growing use of high-throughput flow cytometry and automated hematology analyzers.

https://www.marketsandmarkets.com/Market-Reports/cell-counting-market-157450728.html

By product, the consumables segment is expected to account for the largest share of the cell counting market in 2018

On the basis of product, the consumables segment is expected to account for the largest share of the global cell counting market in 2018. This large share can be attributed to the repeated consumption of consumables and accessories in various cell counting procedures. The growing focus on stem cell and cancer research is one of the major drivers for the growth of the cell counting consumables market along with the growing application of cell counting in quality control procedures in various industries, such as food and beverage, pharmaceutical, biotechnology products manufacturing, environmental monitoring, and water treatment.

Request For Brochure :
https://www.marketsandmarkets.com/pdfdownload.asp?id=157450728

By application, the research applications segment is estimated to hold the largest share in 2018

Based on application, the cell counting market is segmented into research applications, clinical & diagnostic applications, and industrial applications. In 2018, the research applications segment is expected to account for the largest share of the cell counting market. The large share of this segment can be attributed to the growing adoption of various cell counting instruments in research activities propelled by increasing research activities being undertaken for cancer, immunology, infectious diseases, HIV, drug discovery, and stem cells.

By end user, the research institutes segment is estimated to hold the largest share of the cell counting market in 2018

On the basis of end user, the cell counting market is segmented into research institutes, hospitals, clinical laboratories, pharmaceutical & biotechnology companies, and other end users (food and beverage companies and environmental testing companies). The research institutes segment is expected to account for the largest share in 2018. A surge in cell-based research and increasing research investment in the field of AIDS, cancer, infectious diseases, and blood disorders are some of the factors driving the growth of this market segment.

North America to dominate the market in 2018

North America is expected to account for the largest share of the cell counting market in 2018, followed by Europe and Asia Pacific. The growing incidence rate of various infectious diseases, investment initiatives by the government, and presence of high-quality infrastructure for clinical and laboratory research are the major factors responsible for the large share of the North American cell counting market. Moreover, a number of major global players are based in the US, owing to which, the US is a center for innovation in the cell counting market.

The prominent players in the global cell counting market are Danaher Corporation (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Merck (Germany), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Agilent Technologies (US), BioTek Instruments (US), Tecan Group (Switzerland), Roche Diagnostics (Switzerland), Sysmex Corporation (Japan), HORIBA, Ltd. (Japan), Abbott Laboratories (US), and Siemens Healthineers (Germany).

Request For Sample :
https://www.marketsandmarkets.com/requestsample.asp?id=157450728